These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 12722176

  • 1. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
    Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, Fook-Cheong SM, Teoh ML, Yih Y, Wong MC, Zhao Y.
    Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
    [Abstract] [Full Text] [Related]

  • 2. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
    Rissling I, Geller F, Bandmann O, Stiasny-Kolster K, Körner Y, Meindorfner C, Krüger HP, Oertel WH, Möller JC.
    Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
    [Abstract] [Full Text] [Related]

  • 3. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.
    Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shioduka S, Hamaguchi H, Toru M, Shibuya H.
    Alcohol Clin Exp Res; 1998 Jun; 22(4):845-8. PubMed ID: 9660310
    [Abstract] [Full Text] [Related]

  • 4. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
    Paus S, Grünewald A, Klein C, Knapp M, Zimprich A, Janetzky B, Möller JC, Klockgether T, Wüllner U.
    Mov Disord; 2008 Mar 15; 23(4):599-602. PubMed ID: 18175338
    [Abstract] [Full Text] [Related]

  • 5. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
    Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.
    Mov Disord; 2000 Jan 15; 15(1):127-31. PubMed ID: 10634251
    [Abstract] [Full Text] [Related]

  • 6. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R, Toft M, Kachergus J, Hulihan MM, Aasly JO, Klungland H, Farrer MJ.
    Acta Neurol Scand; 2008 Nov 15; 118(5):320-7. PubMed ID: 18485051
    [Abstract] [Full Text] [Related]

  • 7. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J, Hemayatkar M, Toufani H, Abdollahian E.
    Arch Iran Med; 2008 May 15; 11(3):252-6. PubMed ID: 18426314
    [Abstract] [Full Text] [Related]

  • 8. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
    Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H.
    Am J Med Genet; 1994 Dec 15; 54(4):361-4. PubMed ID: 7726209
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings.
    Golimbet VE, Aksenova MG, Nosikov VV, Orlova VA, Kaleda VG.
    Neurosci Behav Physiol; 2003 Mar 15; 33(3):223-5. PubMed ID: 12762588
    [Abstract] [Full Text] [Related]

  • 10. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J, Kucharska-Mazur J, Grzywacz A, Jabłoński M, Rommelspacher H, Samochowiec A, Sznabowicz M, Horodnicki J, Sagan L, Pełka-Wysiecka J.
    Neurosci Lett; 2006 Dec 13; 410(1):1-5. PubMed ID: 17079080
    [Abstract] [Full Text] [Related]

  • 11. [Linkage sib-pair analysis of dopamine receptor D2 gene Taq1A and Taq1B polymorphism and schizophrenia].
    Golimbet VE, Aksenova MG, Nosikov VV, Orlova VA, Kaleda VG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002 Dec 13; 102(4):43-4. PubMed ID: 12001666
    [No Abstract] [Full Text] [Related]

  • 12. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
    Costa-Mallen P, Costa LG, Checkoway H.
    Neurosci Lett; 2005 Sep 09; 385(2):158-62. PubMed ID: 15955630
    [Abstract] [Full Text] [Related]

  • 13. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.
    Mov Disord; 2006 Dec 09; 21(12):2157-64. PubMed ID: 17078049
    [Abstract] [Full Text] [Related]

  • 14. Genetics of Lesch's typology of alcoholism.
    Samochowiec J, Kucharska-Mazur J, Grzywacz A, Pelka-Wysiecka J, Mak M, Samochowiec A, Bienkowski P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):423-7. PubMed ID: 17928119
    [Abstract] [Full Text] [Related]

  • 15. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T, Putzhammer A, Sartor H, Knapp M, Albus M, Borrmann-Hassenbach M, Lichtermann D, Wildenauer D, Schwab S, Maier W, Klein HE, Eichhammer P.
    Psychiatr Prax; 2003 May 15; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [Abstract] [Full Text] [Related]

  • 16. Toward identification of susceptibility genes for sporadic Parkinson's disease.
    Toda T, Momose Y, Murata M, Tamiya G, Yamamoto M, Hattori N, Inoko H.
    J Neurol; 2003 Oct 15; 250 Suppl 3():III40-3. PubMed ID: 14579123
    [Abstract] [Full Text] [Related]

  • 17. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
    McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, Popat RA, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM.
    J Neurol Sci; 2011 Aug 15; 307(1-2):22-9. PubMed ID: 21663922
    [Abstract] [Full Text] [Related]

  • 18. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
    Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A.
    Parkinsonism Relat Disord; 2012 May 15; 18(4):397-9. PubMed ID: 22113132
    [Abstract] [Full Text] [Related]

  • 19. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT, Viernes HM, Farin FM, Smith-Weller T, Checkoway H.
    Mov Disord; 2004 Jan 15; 19(1):76-83. PubMed ID: 14743364
    [Abstract] [Full Text] [Related]

  • 20. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF.
    Mol Psychiatry; 2004 Jul 15; 9(7):711-7. PubMed ID: 14699430
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.